WallStSmart

iTonic Holdings Ltd. (ITOC) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

iTonic Holdings Ltd. stock (ITOC) is currently trading at $0.41. iTonic Holdings Ltd. PS ratio (Price-to-Sales) is 22.11. WallStSmart rates ITOC as Sell.

  • ITOC PE ratio analysis and historical PE chart
  • ITOC PS ratio (Price-to-Sales) history and trend
  • ITOC intrinsic value — DCF, Graham Number, EPV models
  • ITOC stock price prediction 2025 2026 2027 2028 2029 2030
  • ITOC fair value vs current price
  • ITOC insider transactions and insider buying
  • Is ITOC undervalued or overvalued?
  • iTonic Holdings Ltd. financial analysis — revenue, earnings, cash flow
  • ITOC Piotroski F-Score and Altman Z-Score
  • ITOC analyst price target and Smart Rating
ITOC

iTonic Holdings

NASDAQHEALTHCARE
$0.41
$0.13 (45.25%)
52W$0.27
$1.09

📊 No data available

Try selecting a different time range

WallStSmart

Smart Analysis

iTonic Holdings Ltd. (ITOC) · 7 metrics scored

Smart Score

19
out of 100
Grade: F
Avoid
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in price/book. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.

iTonic Holdings Ltd. (ITOC) Key Strengths (1)

Avg Score: 10.0/10
Price/BookValuation
0.9810/10

Trading below book value, meaning the market prices it less than net assets

iTonic Holdings Ltd. (ITOC) Areas to Watch (6)

Avg Score: 1.2/10
Return on EquityProfitability
-101.60%0/10

Company is destroying shareholder value

Operating MarginProfitability
-3082.00%0/10

Losing money on operations

Revenue GrowthGrowth
-67.90%0/10

Revenue declining -67.90%, a shrinking business

Price/SalesValuation
22.112/10

Very expensive at 22.1x annual revenue

Institutional Own.Quality
2.79%2/10

Very low institutional interest at 2.79%

Market CapQuality
$7M3/10

Micro-cap company with very limited liquidity and high volatility

Supporting Valuation Data

Price/Sales (TTM)
22.11
Overvalued

iTonic Holdings Ltd. (ITOC) Detailed Analysis Report

Overall Assessment

This company scores 19/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 1 register as strengths (avg 10.0/10) while 6 fall into concern territory (avg 1.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Book. Valuation metrics including Price/Book (0.98) suggest the stock is attractively priced.

The Bear Case

The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Some valuation metrics including Price/Sales (22.11) suggest expensive pricing. Growth concerns include Revenue Growth at -67.90%, which may limit upside. Profitability pressure is visible in Return on Equity at -101.60%, Operating Margin at -3082.00%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -101.60% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -67.90% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

ITOC Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

ITOC's Price-to-Sales ratio of 22.11x trades at a deep discount to its historical average of 76.07x (28th percentile). The current valuation is 96% below its historical high of 610.19x set in Jul 2025, and 193% above its historical low of 7.54x in Feb 2026. Over the past 12 months, the PS ratio has compressed from ~73.7x as trailing revenue scaled faster than the stock price.

Compare ITOC with Competitors

Top MEDICAL DEVICES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for iTonic Holdings Ltd. (ITOC) · HEALTHCAREMEDICAL DEVICES

The Big Picture

iTonic Holdings Ltd. operates as a stable business with moderate growth and solid fundamentals. Revenue reached 305,220 with 68% decline year-over-year. The company is currently unprofitable, posting a 0.0% profit margin.

Key Findings

Revenue Decline

Revenue contracted 68% YoY. Worth determining whether this is cyclical or structural.

Negative Free Cash Flow

Free cash flow is -3M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.

What to Watch Next

Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact iTonic Holdings Ltd..

Bottom Line

iTonic Holdings Ltd. offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Total Buys
0
Total Sells
0

Data sourced from SEC Form 4 filings

Last updated: 8:25:21 AM

About iTonic Holdings Ltd.(ITOC)

Exchange

NASDAQ

Sector

HEALTHCARE

Industry

MEDICAL DEVICES

Country

USA

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.